Coeliac Disease Trial, Recruiting NCT06500754 Sponsor: Hospital Mutua de Terrassa Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT06500754
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You were 18 years old or older when you were diagnosed with coeliac disease
  • You have been diagnosed with coeliac disease confirmed by intestinal damage (villous atrophy), a positive blood test, and you improved both in symptoms and blood test results after starting a gluten-free diet
  • You have been following a gluten-free diet for at least 2 years and have been sticking to it well
  • Your coeliac-related blood test (anti-transglutaminase IgA) is either negative or only slightly above normal (less than twice the normal level) at the time of joining the trial
  • You are willing and able to provide written consent to participate

Who may not be able to join:

  • People who have a form of coeliac disease that does not respond to a gluten-free diet (called refractory coeliac disease, type 1 or type 2)
  • People who have other bowel conditions such as inflammatory bowel disease, microscopic colitis, or other intestinal disorders
  • People who need to take steroid or immune-suppressing medications
  • People who have had gut surgery or have conditions that can cause a bacterial overgrowth in the small intestine (confirm with trial site)
  • People who are pregnant or breastfeeding
  • People who have serious long-term conditions affecting the lungs, heart, kidneys, or liver (including liver cirrhosis)
  • People with alcohol dependency or drug addiction
  • People with certain mental health conditions including schizophrenia, other psychoses, or bipolar disorder

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Mutua de Terrassa
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 January 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Persistent villous atrophy frequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov